Andrew Regan - 08 Dec 2025 Form 4 Insider Report for CDT Equity Inc. (CDT)

Reporting relationship: Chief Executive Officer, Director, 10%+ Owner
Issuer ticker: CDT
Reported as of: 08 Dec 2025
Net transaction value: +$402,761
SEC form: 4
Accepted by SEC: 22 Dec 2025, 16:05:28 UTC
Prior SEC filing: 22 Sep 2025
Next SEC filing: 14 May 2026
Source filing: View source filing
Reporting owner signature: /s/ Andrew Regan

Key filing fact

Andrew Regan filed Form 4 for CDT Equity Inc. (CDT) on 22 Dec 2025.

Key facts

This page summarizes Andrew Regan's Form 4 filing for CDT Equity Inc. (CDT).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 22 Dec 2025, 16:05.

Change

Previous filing in this sequence was filed on 22 Sep 2025.
Current net transaction value: +$402,761.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (2)

CIK 0001991325 Primary reporting owner

Regan Andrew

Relationship: Chief Executive Officer, Director, 10%+ Owner
Address: 4851 TAMIAMI TRAIL NORTH, SUITE 200, NAPLES
Signature: /s/ Andrew Regan
Signature date: 22 Dec 2025

CIK 0001990829

Corvus Capital Ltd.

Relationship: 10%+ Owner
Address: FLOOR 2, WILLOW HOUSE, CRICKET SQUARE, P.O. BOX 709,, GRAND CAYMAN, CAYMAN ISLANDS
Signature: CORVUS CAPITAL LTD. By: /s/ Andrew Regan, Name: Andrew Regan, Title: Chief Executive Officer
Signature date: 22 Dec 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDT transaction

Common Stock

Award

Transaction value: $402,392
Shares: +224,800
Change %: +8978%
Price: $1.79
Shares after: 227,304
Date: 08 Dec 2025
Ownership: By Corvus Capital Ltd.
Footnotes: F1, F2, F3, F6

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 140,005
Date: 08 Dec 2025
Ownership: Direct

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 19,349
Date: 08 Dec 2025
Ownership: By Manoira Corporation
Footnotes: F4, F6

CDT holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 14
Date: 08 Dec 2025
Ownership: By Algo Holdings, Inc.
Footnotes: F5, F6

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDT transaction Derivative

Pre-Funded Warrants

Award

Transaction value: $369
Shares: +3,685,815
Change %
Price: $0.000100
Shares after: 3,685,815
Date: 08 Dec 2025
Ownership: By Corvus Capital Ltd.
Underlying class: Common Stock
Underlying amount: 3,685,815
Exercise price: $0.000100
Footnotes: F1, F3, F6, F7

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 7 footnotes

Footnote F1

On December 8, 2025, CDT Equity Inc. (the "Company") and Corvus Capital Limited ("Corvus") entered into a Sale and Purchase Agreement, pursuant to which the Company issued to Corvus 224,800 shares of common stock, par value $0.0001 per share of the Company, and pre-funded warrants to purchase up to 3,685,815 shares of Common Stock (the "Pre-Funded Warrants"), pursuant to the acquisition of Conduit Pharmaceuticals Limited and its liabilities.

Footnote F2

Based on the closing price per share of Common Stock on December 7, 2025.

Footnote F3

These shares of Common Stock are owned of record by Corvus.

Footnote F4

These shares of Common Stock are owned of record by Manoira Corporation ("Manoira").

Footnote F5

These shares of Common Stock are owned of record by Algo Holdings, Inc. ("Algo").

Footnote F6

Corvus is the owner of 99.0% of the equity interests of Manoira and Algo is a wholly owned subsidiary of Corvus, and, therefore, may also be deemed to beneficially own the shares of Common Stock held of record by Manoira and Algo. Dr. Regan is the sole director of Manoira and the Chief Executive Officer and sole shareholder of Corvus. By virtue of these relationships, Dr. Regan may be deemed to beneficially own the shares of Common Stock held of record by Manoira, Algo and Corvus. Each of Corvus and Dr. Regan disclaims any such beneficial ownership, including with respect to the Pre-Funded Warrant Shares, except to the extent of its or his pecuniary interest therein.

Footnote F7

Until exercised in full.